{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:28:47Z","timestamp":1771666127256,"version":"3.50.1"},"reference-count":37,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> Abnormal accumulation of intracellular calcium following traumatic brain injury (TBI) is thought to contribute to a cascade of cellular events that lead to neuropathological conditions. Therefore, the possibility that specific calcium channel antagonists might exert neuroprotective effects in TBI has been of interest. The focus of this study was to examine whether Ziconotide produces such neuroprotective effects.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> The authors report that the acceleration\u2014deceleration model of TBI developed by Marmarou, et al., induces a long-lasting deficit of neuromotor and behavioral function. The voltage-sensitive calcium channel blocker Ziconotide (also known as SNX-111 and CI-1009) exerts neuroprotective effects in this model of diffuse brain injury (DBI) in rats. The dose and time of injection of Ziconotide chosen for the present study was based on the authors' previous biochemical studies of mitochondria. Rats were trained in a series of motor and memory tasks, following which they were subjected to DBI using the Marmarou, et al., model. At 3, 5, and 24 hours, all rats were injected with 2 mg\/kg Ziconotide for a total cumulative dose of 6 mg\/kg Ziconotide. Control brain-injured animals were injected with an equal volume of saline vehicle at each of these time points. The rats were tested for motor and cognitive performance at 1, 3, 7, 14, 21, 28, 35, and 42 days postinjury. Saline-treated rats displayed severe motor and cognitive deficits after DBI. Compared with saline-treated control animals, rats treated with Ziconotide displayed better motor performance during inclined plane, beam balance, and beam walk tests; improved memory while in the radial arm maze; and improved learning while in the Morris water maze.<\/jats:p><jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> These results demonstrated that the acceleration\u2014deceleration model, which had been developed by Marmarou, et al., induces severe motor and cognitive deficits. We also demonstrated that Ziconotide exhibits substantial neuroprotective activity in this model of TBI. Improvement was observed in both motor and cognitive tasks, even though treatment was not initiated until 3 hours after injury. These findings support the development of neuronal N-type calcium channel antagonists as useful therapeutic agents in the treatment of TBI.<\/jats:p>","DOI":"10.3171\/jns.2000.93.5.0821","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:27:13Z","timestamp":1242235633000},"page":"821-828","source":"Crossref","is-referenced-by-count":57,"title":["Neurobehavioral protection by the neuronal calcium channel blocker Ziconotide in a model of traumatic diffuse brain injury in rats"],"prefix":"10.3171","volume":"93","author":[{"given":"Robert F.","family":"Berman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bon H.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Paul","family":"Muizelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Pharmacol Exp Ther","first-page":"1243","article-title":"Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.","volume":"279","author":"Bowersox","year":"1996"},{"key":"b2","series-title":"J Pharmacol Exp Ther","first-page":"248","article-title":"Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel \u03c9-conopeptides and \u03c9-agatoxin-IVA.","volume":"273","author":"Bowersox","year":"1995"},{"key":"b3","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/jcbfm.1994.121","article-title":"A selective N-type Ca2+-channel blocker prevents CA1 24 hr following severe forebrain ischemia and reduces infarction following focal ischemia.","volume":"14","author":"Buchan","year":"1994"},{"key":"b4","series-title":"J Pharmacol Exp Ther","first-page":"1117","article-title":"Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia.","volume":"269","author":"Chaplan","year":"1994"},{"key":"b5","series-title":"Ann NY Acad Sci","first-page":"162","article-title":"Calcium and excitotoxic neuronal injury.","volume":"747","author":"Choi","year":"1994"},{"key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3171\/jns.1987.67.1.0110","article-title":"A fluid percussion model of experimental brain injury in the rat.","volume":"67","author":"Dixon","year":"1987"},{"key":"b7","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0006-8993(93)90064-T","article-title":"Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study.","volume":"624","author":"Fineman","year":"1993"},{"key":"b8","series-title":"J Neurotrauma","first-page":"610","article-title":"Behavioral, morphological and electrophysiological effects of diffuse axonal injury in rats.","volume":"13","author":"Folkerts","year":"1996"},{"key":"b9","series-title":"Pflugers Arch Eur J Physiol","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/BF00374813","article-title":"Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC \u03c9-conopeptides.","volume":"429","author":"Fox","year":"1995"},{"key":"b10","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0028-3908(05)80012-7","article-title":"Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.","volume":"33","author":"Gaur","year":"1994"},{"key":"b11","series-title":"Science","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1126\/science.7716515","article-title":"Calcium signaling in neurons: molecular mechanisms and cellular consequences.","volume":"268","author":"Ghosh","year":"1995"},{"key":"b12","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.1996.85.1.0082","article-title":"Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group.","volume":"85","author":"Harders","year":"1996"},{"key":"b13","series-title":"Acta Neurochir Suppl","first-page":"521","article-title":"Administration of an omegaconopeptide one hour following traumatic brain injury reduces 45calcium accumulation.","volume":"60","author":"Hovda","year":"1994"},{"key":"b14","series-title":"J Neurosurg","first-page":"698","article-title":"The role of calcium and cellular membrane dysfunction in experimental trauma and subarachnoid hemorrhage.","volume":"6","author":"Hubschmann","year":"1985"},{"key":"b15","series-title":"Exp Brain Res","first-page":"22","article-title":"Effects of T-type, L-type, N-type, P-type and Q-type calcium channel blockers on stimulus-induced pre- and postsynaptic calcium fluxes in rat hippocampal slices.","volume":"109","author":"Igelmund","year":"1996"},{"key":"b16","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0006-8993(90)91229-A","article-title":"Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat.","volume":"526","author":"Lyeth","year":"1990"},{"key":"b17","series-title":"Pain","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0304-3959(94)00094-U","article-title":"Effects of continuous intrathecal infusion of \u03c9-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats.","volume":"60","author":"Malmberg","year":"1995"},{"key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3171\/jns.1994.80.2.0291","article-title":"A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics.","volume":"80","author":"Marmarou","year":"1994"},{"key":"b19","series-title":"Ann Rev Pharmacol Toxicol","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev.pa.35.040195.003423","article-title":"Antagonists of neuronal calcium channels: structure, function, and therapeutic implications.","volume":"35","author":"Miljanich","year":"1995"},{"key":"b20","series-title":"Science","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/science.2432656","article-title":"Multiple calcium channels and neuronal function.","volume":"235","author":"Miller","year":"1987"},{"key":"b21","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3171\/jns.1993.78.3.0375","article-title":"Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial.","volume":"78","author":"Muizelaar","year":"1993"},{"key":"b22","series-title":"Biochemistry","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1021\/bi00025a013","article-title":"Structure\u2014activity analysis of a Conus peptide blocker of N-type neuronal calcium channels.","volume":"34","author":"Nadasdi","year":"1995"},{"key":"b23","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00004647-199603000-00011","article-title":"Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels.","volume":"16","author":"Nilsson","year":"1996"},{"key":"b24","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/neu.1997.14.677","article-title":"Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?","volume":"14","author":"Obrenovitch","year":"1997"},{"key":"b25","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1471-4159.1992.tb09310.x","article-title":"Inhibition of ischemia-induced dopamine release by \u03c9-Conotoxin, a calcium channel blocker, in the striatum of spontaneously hypertensive rats: an in vivo brain dialysis study.","volume":"58","author":"Ooboshi","year":"1992"},{"key":"b26","series-title":"Science","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.386513","article-title":"Calcium dependence of toxic cell death: a final common pathway.","volume":"206","author":"Schanne","year":"1979"},{"key":"b27","series-title":"Neurol Res","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/01616412.1989.11739885","article-title":"Accumulation of calcium in the brain following head trauma.","volume":"11","author":"Shapira","year":"1989"},{"key":"b28","series-title":"Novel Therapies for CNS Injuries: Rationales and Results.","first-page":"137","article-title":"Excitatory amino acid pharmacology in traumatic brain injury","author":"Smith","year":"1996"},{"key":"b29","series-title":"J Cereb Blood Flow Metab","first-page":"S700","article-title":"Postischemic treatment with the \u03c9-conopeptide SNX-111 protects against neuronal loss after global cerebral ischemic damage.","author":"Smith","year":"1993"},{"key":"b30","series-title":"Proc Natl Acad Sci USA","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1073\/pnas.90.16.7894","article-title":"A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia.","volume":"90","author":"Valentino","year":"1993"},{"key":"b31","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3171\/jns.2000.93.5.0815","article-title":"Impaired cerebral mitochondrial function after traumatic brain injury in humans.","volume":"93","author":"Verweij","year":"2000"},{"key":"b32","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3171\/jns.2000.93.5.0829","article-title":"Improvement in mitochondrial dysfunction as a new surrogate efficiency measure for preclinical trials: dose\u2014response and time-window profiles for administration of the calcium channel blocker Ziconotide in experimental brain injury.","volume":"93","author":"Verweij","year":"2000"},{"key":"b33","series-title":"Neurol Res","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/01616412.1997.11740821","article-title":"Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNZ-111).","volume":"19","author":"Verweij","year":"1997"},{"key":"b34","series-title":"Trends Neurosci","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0166-2236(96)01015-6","article-title":"Presynaptic inhibition of elicited neurotransmitter release.","volume":"20","author":"Wu","year":"1997"},{"key":"b35","series-title":"J Pharmacol Exp Ther","first-page":"666","article-title":"Synthetic \u03c9-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats.","volume":"274","author":"Xiao","year":"1995"},{"key":"b36","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/neu.1997.14.23","article-title":"Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury.","volume":"14","author":"Xiong","year":"1997"},{"key":"b37","series-title":"J Neurotrauma","first-page":"S9","article-title":"Role of calcium in central nervous systems injuries.","volume":"9","author":"Young","year":"1992"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/93\/5\/article-p821.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/93\/5\/article-p821.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/93\/5\/article-p821.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:28:14Z","timestamp":1679869694000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/93\/5\/article-p821.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":37,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.2000.93.5.0821","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}